Whitegate Investment Counselors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-27,820
| Closed | -$1.34M | – | 157 |
|
|
2021
Q3 | $1.34M | Sell |
27,820
-100
| -0.4% | -$4.8K | 0.19% | 98 |
|
|
2021
Q2 | $1.17M | Hold |
27,920
| – | – | 0.17% | 108 |
|
|
2021
Q1 | $941K | Hold |
27,920
| – | – | 0.14% | 117 |
|
|
2020
Q4 | $975K | Hold |
27,920
| – | – | 0.16% | 106 |
|
|
2020
Q3 | $969K | Hold |
27,920
| – | – | 0.18% | 102 |
|
|
2020
Q2 | $914K | Hold |
27,920
| – | – | 0.18% | 101 |
|
|
2020
Q1 | $840K | Buy |
27,920
+400
| +1% | +$12K | 0.2% | 96 |
|
|
2019
Q4 | $796K | Buy |
27,520
+800
| +3% | +$23.1K | 0.14% | 117 |
|
|
2019
Q3 | $691K | Buy |
26,720
+1,700
| +7% | +$44K | 0.14% | 122 |
|
|
2019
Q2 | $639K | Buy |
25,020
+13,900
| +125% | +$355K | 0.13% | 125 |
|
|
2019
Q1 | $291K | Buy |
11,120
+1,250
| +13% | +$32.7K | 0.06% | 161 |
|
|
2018
Q4 | $227K | Buy |
+9,870
| New | +$227K | 0.05% | 172 |
|